The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCBX.L Regulatory News (CBX)

  • There is currently no data for CBX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

19 Jul 2005 18:09

Cubus Lux plc19 July 2005 CUBUS LUX PLC Board changes Directors' dealings Board changes Cubus Lux Plc ("Cubus" or the "Company") are pleased to announce the appointmentof Mr. Gerhard Huber (aged 45) and Mr. Michael Martin Janssen (aged 39) asexecutive chairman and non-executive director respectively. Gerhard Huber brings with him many years of experience in banking, real estatedevelopment and tourism in Croatia. Michael Janssen brings with him years ofexperience in financial management and investor relations. As part of these appointments, Moshe Har Adir has stepped down from his positionas executive CEO and director. Haggai Ravid has stepped down as interim chairmanand will remain a non-executive director. Mr. Gerhard Huber commented - "I am pleased to have the opportunity to bring inmy expertise to Cubus with our aim of growing it into the premier tourismcompany in Croatia." Details on directors Gerhard Huber Current directorshipsXelector Ltd Past directorshipsGSX Leisure Limited - a company which was put into liquidation. Michael Janssen Current directorshipsFAS AGCryptovision GmbHVC on Target GmbH Past directorshipsNone There are no further disclosures required to be made in respect of Mr. Huber andMr. Janssen with regard to paragraph (g) of Schedule 2 of the AIM Rules. Directors' dealings In conjunction with the board changes Mr. Har Adir has entered into an agreementto sell 9,878,763 ordinary shares, representing approximately 44.7% of theissued share capital of the Company to various entities and individuals,including Mr. Huber and Mr. Janssen. Completion of this share sale is due totake place on 22 July 2005, following which Mr. Huber and Mr. Janssen'sinterests in the Company will be as follows: Number of shares % of issued share capital Gerhard Huber 2,160,763 9.5%Michael Janssen 1,564,000 6.8% The Company is not currently subject to the City Code on Takeovers and Mergers. For information contact: Graham HerringThreadneedle Communications - 020 7531 2620 Olly CairnsCorporate Synergy Plc - 020 7626 2244 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
28th Mar 20224:35 pmRNSPrice Monitoring Extension
28th Mar 202211:00 amRNSPrice Monitoring Extension
22nd Mar 20227:00 amRNSDirectorate change
14th Mar 20224:41 pmRNSSecond Price Monitoring Extn
14th Mar 20224:36 pmRNSPrice Monitoring Extension
14th Mar 20222:05 pmRNSSecond Price Monitoring Extn
14th Mar 20222:00 pmRNSPrice Monitoring Extension
14th Mar 20227:00 amRNSLaunch of outdoor marketing campaign
8th Mar 202211:03 amRNSShare purchase by CEO
7th Mar 202211:05 amRNSSecond Price Monitoring Extn
7th Mar 202211:00 amRNSPrice Monitoring Extension
4th Mar 20224:41 pmRNSSecond Price Monitoring Extn
4th Mar 20224:36 pmRNSPrice Monitoring Extension
2nd Mar 20227:00 amRNSExercise of Warrants
1st Mar 20227:00 amRNSLaunch of Rejuvenating Cannabinoid Face Serum
23rd Feb 20224:41 pmRNSSecond Price Monitoring Extn
23rd Feb 20224:36 pmRNSPrice Monitoring Extension
23rd Feb 20222:06 pmRNSSecond Price Monitoring Extn
23rd Feb 20222:01 pmRNSPrice Monitoring Extension
21st Feb 202211:05 amRNSSecond Price Monitoring Extn
21st Feb 202211:00 amRNSPrice Monitoring Extension
21st Feb 20229:05 amRNSSecond Price Monitoring Extn
21st Feb 20229:00 amRNSPrice Monitoring Extension
21st Feb 20227:00 amRNSStrategy and trading update
2nd Feb 20227:00 amRNSWhite paper on cannabinoids and skin aging
7th Jan 20221:00 pmRNSResults of Annual General Meeting
15th Dec 20217:00 amRNSAnnual General Meeting update
8th Dec 20217:00 amRNSGrant of Options to CEO
6th Dec 20211:57 pmRNSPosting of Annual Report and Notice of AGM
6th Dec 20217:00 amRNSAppointment of new CEO
3rd Dec 20217:00 amRNSAnnual results
1st Dec 20217:00 amRNSLaunch of inaugural products & ecommerce platform
11th Nov 20217:00 amRNSAdvertising and PR agencies appointed
8th Nov 20212:05 pmRNSSecond Price Monitoring Extn
8th Nov 20212:00 pmRNSPrice Monitoring Extension
8th Nov 202111:05 amRNSSecond Price Monitoring Extn
8th Nov 202111:00 amRNSPrice Monitoring Extension
1st Nov 20217:00 amRNSGrant of Share Options and update on warrants
4th Oct 20219:06 amRNSSecond Price Monitoring Extn
4th Oct 20219:00 amRNSPrice Monitoring Extension
4th Oct 20217:00 amRNSDirector dealings & TR1 notification
16th Aug 20217:00 amRNSSupply agreement signed with Chanelle McCoy Health
2nd Aug 20217:00 amRNSShare disposal by significant shareholder
28th Jul 20212:06 pmRNSSecond Price Monitoring Extn
28th Jul 20212:00 pmRNSPrice Monitoring Extension
10th Jun 20217:00 amRNSSupply agreement signed with Willow Biosciences
25th May 20217:00 amRNSCellular Goods Interim Results
6th May 20217:00 amRNSGrant of Warrants and Extension of Exercise Period
20th Apr 20212:00 pmRNSPrice Monitoring Extension
12th Apr 20217:00 amRNSCellular Goods boosts team with five appointments

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.